Search clinical trials for: Brentuximab vedotin
Total 411 results
-
Massachusetts General HospitalSeagen Inc.CompletedHodgkin LymphomaUnited States
-
Fudan UniversityRecruitingHER2-positive Gastric Cancer | ImmunotherapyChina
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
University of CologneActive, not recruiting
-
Massachusetts General HospitalCompleted
-
Marjolein SpieringMillennium: The Takeda Oncology CompanyUnknownHodgkin Lymphoma | Relapse | RefractoryNetherlands, France, Denmark, United Kingdom
-
Qilu Hospital of Shandong UniversityNot yet recruitingHER2-positive Gastric CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Henan Cancer HospitalNot yet recruiting
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
St. Jude Children's Research HospitalSeagen Inc.Active, not recruitingStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage II Childhood Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityNot yet recruiting
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
Instituto de Ciencia y Tecnología de Alimentos...Completed
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsNot yet recruiting
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
Alshimaa Abbas Mohamed EbrahimActive, not recruitingAcne VulgarisEgypt
-
Radboud University Medical CenterRecruiting
-
RemeGen Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Mesothelioma | CD30-Positive Neoplastic Cells PresentUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Seagen Inc.Merck Sharp & Dohme LLC; GenmabRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Exocrine Pancreatic Cancer | Carcinoma, Squamous Cell of Head and NeckUnited States, Canada, France, Germany, Italy, Spain, United Kingdom, Puerto Rico
-
Shanghai Zhongshan HospitalNot yet recruitingColorectal Neoplasms
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
Mitchell CairoCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; H. Lee Moffitt... and other collaboratorsCompleted
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Telix International Pty LtdMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
New York Medical CollegeRecruitingFollicular Lymphoma | B-cell Lymphoma | Hodgkin Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Richter Syndrome | Transformed Non-Hodgkin LymphomaUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
Guoxin LiNot yet recruiting
-
CuraGen CorporationCompletedBreast CancerUnited States
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
GE HealthcareCompletedMild Cognitive Impairment | Alzheimer's Disease
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Poland, Sweden, Hungary, Italy
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Hoffmann-La RocheCompletedRelapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell LymphomaUnited States, Spain, United Kingdom
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-Cell LymphomaUnited States, United Kingdom, Korea, Republic of, Finland, Brazil, China, Mexico, Canada, Germany, India, Turkey, Greece, Italy, Spain, France, Ireland
-
Mayo ClinicRecruitingStage IV Penile Cancer AJCC v8 | Stage III Penile Cancer AJCC v8 | Metastatic Penile Squamous Cell Carcinoma | Unresectable Penile Squamous Cell CarcinomaUnited States
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States